In line with this, we found that IDO1 inhibition alone (epacadostat), TDO2 inhibition alone (680c91), and dual TDO2/IDO1 inhibition (AT-0174) all reduced PD-L1 expression on ovarian tumor cells. This evidence concerns the gene IDO1 and ovarian neoplasm.